000 01097 a2200325 4500
005 20250516032144.0
264 0 _c20110815
008 201108s 0 0 eng d
022 _a1750-7448
024 7 _a10.2217/imt.11.12
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSaleem, Benazir
245 0 0 _aRemission in inflammatory arthritis: a new immunological target.
_h[electronic resource]
260 _bImmunotherapy
_cApr 2011
300 _a459-63 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMethotrexate
_xtherapeutic use
650 0 4 _aRemission Induction
_xmethods
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aWalsh, Ceara A E
700 1 _aEmery, Paul
773 0 _tImmunotherapy
_gvol. 3
_gno. 4
_gp. 459-63
856 4 0 _uhttps://doi.org/10.2217/imt.11.12
_zAvailable from publisher's website
999 _c20731319
_d20731319